Sarbani Chaudhuri, an officer of Rocket Pharmaceuticals, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 4,872 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ:RCKT.

Key Highlights

  • Proposed sale: 4,872 shares of Rocket Pharmaceuticals common stock, with an aggregate market value of $11,335.20, according to the filing.
  • Source of shares: The securities were acquired on November 5, 2026, through restricted stock vesting from the issuer, with payment classified as compensation.
  • Approximate sale date: November 9, 2026, through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917.
  • Shares outstanding: The filing reports 109,774,597 shares of common stock outstanding.
  • Prior sales: The filing discloses a prior sale of 4,701 shares on August 11, 2026, with gross proceeds of $16,450.68, by the same seller within the past three months.
  • Purpose noted: The filing states the sale "includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution."

Rocket Pharmaceuticals Officer Files Rule 144 Notice for Restricted Stock Vesting Sale

Sarbani Chaudhuri, identified in the filing as an officer of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), submitted a Form 144 notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. The filing, dated November 9, 2026, covers 4,872 shares of common stock with a reported aggregate market value of $11,335.20. The broker named in the filing is Fidelity Brokerage Services LLC.

According to the filing, the shares to be sold were acquired on November 5, 2026, through a restricted stock vesting transaction from the issuer, Rocket Pharmaceuticals, Inc., with the nature of payment listed as compensation. The filing notes that the sale "includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution," which the company disclosed as the stated purpose in the remarks section.

The filing also discloses a prior sale within the past three months: Chaudhuri sold 4,701 shares on August 11, 2026, generating gross proceeds of $16,450.68. At the time of this notice, the filing reports 109,774,597 total shares of common stock outstanding for Rocket Pharmaceuticals, Inc. The issuer's address is listed as 350 Fifth Avenue, Suite 7530, New York, New York 10118, with SEC File Number 001-36829.

What Was Disclosed

A Form 144 notice was filed on November 9, 2026, by officer Sarbani Chaudhuri of Rocket Pharmaceuticals, Inc., covering a proposed sale of 4,872 shares acquired via restricted stock vesting, with an aggregate market value of $11,335.20, intended in part to cover tax obligations from the equity award settlement.